Tumgik
#Neurorehabilitation Devices Market
bommagoni · 5 months
Text
Neurorehabilitation Devices Market Size, Growth Analysis 2030
0 notes
avikabohra6 · 7 months
Text
0 notes
wiseguy1122 · 2 years
Text
9th Nov 2022 Neurorehabilitation Devices Market SWOT Analysis, Future Growth, Major Key Players, Opportunity and Forecast 2030
Neurorehabilitation Devices market is experiencing a surge in sales across the globe, and it has been considerably boosted by technological advancement.
0 notes
healthtechpulse · 2 months
Link
0 notes
ramkumarss · 1 year
Text
Neurorehabilitation Devices Market Share Growing at High CAGR
According to Precision Business Insights, the global Neurorehabilitation Devices Market is poised to grow at a significant CAGR of 12.4% from 2023-2029
The global neurorehabilitation devices market size was valued at USD 1.26 billion in 2022 and is poised to grow at a significant CAGR of 12.4% during the forecast period 2023-29. It also includes market size and projection estimations for each of the five major regions from 2023 to 2029. The research report includes historical data, trending features, and market growth estimates for the future. Furthermore, the study includes a global and regional estimation and further split by nations and categories within each region. The research also includes factors and barriers to the neurorehabilitation devices market growth, as well as their impact on the market's future growth. The report gives a comprehensive overview of both primary and secondary data.  
View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/neurorehabilitation-devices-market                      
The global neurorehabilitation devices market segmentation: 1) By Product Type : Non-invasive Stimulators, Wearable Devices, Neurorobotic System, Brain-computer Interface.
2) By Disease Type : Brain Stroke, Parkinson's Disease, Cerebral Palsy, Traumatic Brain Injury, Others.
3) By End-User : Hospitals, Clinics, Ambulatory Surgical Canters.
The primary factors of the neurorehabilitation devices market drivers are the Increase in the prevalence of neurological diseases. The neurorehabilitation devices market report helps to provide the best results for business enhancement and business growth. It further helps to obtain the reactions of consumers to a novel product or service. It becomes possible for business players to take action for changing perceptions. It uncovers and identifies potential issues of the customers. It becomes easy to obtain the reactions of the customers to a novel product or service. It also enlightens further advancement, so it suits its intended market.
The neurorehabilitation devices marketresearchreport gives a comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America was the largest region in the neurorehabilitation devices market report, accounting for the highest share in 2022. It was followed by Asia Pacific, and then the other regions. Request sample report at - https://www.precisionbusinessinsights.com/request-sample/?product_id=19295                    The important profiles and strategies adopted by neurorehabilitation devices market key players are Medtronic plc (Ireland), Abbott Laboratories (U.S.), Hocoma AG (DIH International Ltd.) (Switzerland), Ekso Bionics Holding Inc. (U.S.), Interactive Motion Technologies (U.S.), Bionik laboratories Corp. (Canada), Tyromotion (Austria), Bioxtreme Robotics Rehabilitation (Israel), Civitas Solutions (U.S.), Neurostyle Pte Ltd. (Singapore), covered here to help them in strengthening their place in the market.
About Precision Business Insights: We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: [email protected] Kemp House, 152 – 160 City Road, London EC1V 2NX Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
0 notes
industryinsights · 2 years
Link
0 notes
navabharatlive · 2 years
Link
0 notes
market-reports90 · 2 years
Text
The recent developments in the form of exoskeletons to provide body support to physically disabled and traumatized patients are driving the growth of the neurorobotics segment. However, the Lack of effective training modalities for robotic devices is one of the major factors that is said to reduce the growth of the Neurorehabilitation Devices Market.
2 notes · View notes
communicationblogs · 18 days
Text
Neurorehabilitation Devices Market — Forecast(2024–2030)
Neurorehabilitation Devices Market Overview
Tumblr media
Projected to reach USD 5.63 billion by 2030, growing at a CAGR of 14.32% from 2024 to 2030.Neurorehabilitation is a complex medical process that aims to aid the recovery from a nervous system injury and minimize the functional alterations resulting from it. Neurorehabilitation Devices are designed to help and treat patients with the nervous system or neurological diseases. The use of neurorehabilitation devices enhances the intensity and quality of the neurorehabilitation process and ensures optimal rehabilitation of patients with neurological disorders. Technological advancements in transcranial magnetic stimulation and brain computer interface, increasing demand for the appropriate and efficient neuro-rehab devices for Cerebral palsy, growing demand for neuro-robotic devices to provide different ways of treatment depending on the specific function to be restored, increase in the demand for prosthetics devices in the treatment of various diseases and rise in the number of patients suffering from movement disabilities are all the factors that are set to drive the growth of the global Neurorehabilitation Devices Market for the period 2024–2030.
Request Sample
Neurorehabilitation Devices Market Report Coverage
The report: “Neurorehabilitation Devices Market Forecast (2024–2030)”, by Industry ARC covers an in-depth analysis of the following segments of the Neurorehabilitation Devices Market.
By Product Type: Neurorobotics, Brain Computer Interface, Wearable Devices, and Non-invasive Stimulators. By Disease: Stroke, Multiple Sclerosis, Cerebral Palsy, Parkinson’s Disease, and Others. By Geography- North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and the Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, Chile, Colombia, and Rest of South America), and Rest of the World (the Middle East, and Africa).
Inquiry Before Buying
Key Takeaways
Geographically, North America Neurorehabilitation Devices Market accounted for the highest revenue share in 2021 and it is poised to dominate over the period 2024–2030 owing to the technological advancements in electrostimulation for the treatment of spinal cord injuries and an increase in the demand for prosthetics devices.
The recent developments in the form of exoskeletons to provide body support to physically disabled and traumatized patients are driving the growth of the neurorobotics segment. However, the Lack of effective training modalities for the robotic devices is one of the major factors that is said to reduce the growth of the Neurorehabilitation Devices Market.
A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Neurorehabilitation Devices Market Report.
Schedule a Call
Neurorehabilitation Devices Market Segmentation Analysis- By Product Type :
The Neurorehabilitation Devices Market-based on the Product Type can be further segmented into Neurorobotics, Brain Computer Interface, Wearable Devices, and Non-invasive Stimulators. The Neurorobotics segment held the largest share in 2021 owing to the growing investments by the manufacturers to develop novel systems and platforms. Neurorobotics have the potential for accurate assessment of motor function to assess the patient status, measure the therapy progress, and give the patient and therapist real-time feedback on movement performance. The recent developments in neurorobotics in the form of exoskeletons to provide body support to the physically disabled and traumatized patients are driving the growth of the Neurorehabilitation Devices Market.
Brain Computer Interface is estimated to be the fastest-growing segment with a CAGR of 16.7% over the period 2024–2030. This is owing to the rise in technological developments facilitating communication and movement in paralytic patients. The ability to acquire signals, analyze, and translates them into commands that are relayed to an output device to carry out the desired action is further propelling the demand for brain computer interface devices, which in turn is driving the growth of the market.
Buy Now
Neurorehabilitation Devices Market Segmentation Analysis- By Disease
The Neurorehabilitation Devices Market-based by Disease can be further segmented into Stroke, Multiple Sclerosis, Cerebral Palsy, Parkinson’s Disease, and Others. The Stroke segment held the largest share in 2021 and is also estimated to be the fastest-growing segment with a CAGR of 16.5% over the period 2024–2030. The growth in this segment is owing to the factors such as the growing focus by the healthcare companies to develop new solutions for the treatment of stroke, the rise in the prevalence of stroke among the people suffering from lifestyle diseases, and the growing aging population. Growing guidelines by the health commissions for developing advanced technologies for treating the people suffering from strokes is driving the growth of the Neurorehabilitation Devices Market. Parkinson’s disease segment held the second-largest share in 2021 owing to the factors such as the increase in the government funding for research and development activities for developing new technologies for the treatment of the Parkinson’s disease, rising healthcare awareness among the patients, and growing prevalence of Parkinson’s disease in the developed nations.
Neurorehabilitation Devices Market Segmentation Analysis- By Geography
The Neurorehabilitation Devices Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held a dominant market share of 36% in the year 2021. The growth in this segment is owing to factors such as the growing incidence rate of neurological diseases, the rise in the number of patients suffering from movement disabilities, and technological advancements in electrostimulation and transcranial magnetic stimulation for the treatment of spinal cord injuries. The presence of major players in the region is driving the growth of the market.
Asia-Pacific is estimated to be the fastest-growing segment over the period 2024–2030. The growth in this segment is owing to the factors such as an increase in the awareness coupled with constantly improving healthcare infrastructure, growing strategic initiatives by the key players to expand the operations in the region, increasing incidences of Alzheimer’s and Parkinson’s disease, and the rise in the investment for the research and development activities.
Neurorehabilitation Devices Market Drivers
Technological Advancements in Electrostimulations is a Key Factor in Market Growth.
According to the National Center for Biotechnology Information (NCBI) research in 2019, adding advanced electrostimulation to Standard Wound Care in all wound types increases efficiency by an extra 26.7%. New technologies in electrostimulation for the treatment of spinal cord injuries are enhancing the growth of the neurorehabilitation devices market. Researchers across the world are developing a new multi-electrode to stimulate the spinal cord at different points to improve the patient’s quality of life. This new electrode is capable of deploying diversified electric messages to different fibers of the cord in a targeted and independent manner, which is driving the growth of the Neurorehabilitation Devices Market.
Rise in the Demand for Neuro-robotic Devices is Propelling the Market Growth.
According to The IEEE Robotics and Automation Magazine, the behavior control ability of neuro-robotic devices was approximately 20,000 neurons and nearly 5,00,000 synaptic connections, and also all of the are updated in real-time to keep up with the active sensors. Neuro-robotic devices combined with neuroscience and rehabilitation became the standard method in the treatment of neurological disorders as it provides different ways of treatment, depending on the specific function to be restored. The technological advancements in robotics and its combination with neuroscience have led to the emergence of next-generation rehabilitation techniques, which is further propelling the growth of the Neurorehabilitation Devices Market.
Neurorehabilitation Devices Market Challenges
Lack of Effective Training Modalities in the Robotic Devices Is Hampering the Growth of the Neurorehabilitation Devices Market.
According to the Journal of NeuroEngineering and Rehabilitation, Passive training modalities are very less for acute than for chronic subjects with only 24% of the groups of acute trained with these modalities in 2019. Robotic neurorehabilitation is gaining prominence in the neurorehabilitation devices market. With the launch of novel technologies, the key companies are enhancing the capabilities of robots to offer cost-effective solutions in clinical practice. However, the lack of effective training modalities for these robotic devices is acting as a major challenge for the healthcare companies to design robotic devices, which is estimated to reduce the growth of the Neurorehabilitation devices Market.
Neurorehabilitation Devices Industry Outlook
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Neurorehabilitation Devices Market. The top 10- Neurorehabilitation Devices Market companies are-
Biometrics Ltd
Bionik Laboratories
Bioxtreme Robotics Rehabilitation
Bioness Inc
Ekso Bionics
Ectron Ltd
Kinestica
Medtronic PLC
Kinova Robotics
Hocoma AG
Recent Developments
In February 2022, MindMaze, a neurotherapeutics company secured a USD 105 million financing round to accelerate its commercial growth plans, enhance ongoing R&D and consolidate the clinical development pipeline of its digital therapeutic solutions for various neurological diseases.
In November 2019, Ekso Bionics Holdings has launched the EksoNR, the next generation of its EksoGT robotic exoskeleton, developed for neurorehabilitation purposes. It is an intuitive exoskeleton that empowers patients recovering from stroke and other conditions to learn to walk again with a more natural gait. These features and software enhancements are aimed to get more out of rehabilitation sessions.
In January 2019, Bionik Laboratories has launched InMotion Connect to target the clinical need and improve technology and update the traditional neurorehabilitation process to increase the return on assets. These systems are used for the clinical rehabilitation of stroke survivors. These improved generation InMotion ARM/HAND were developed based on the same principles of neuroplasticity.
For more Lifesciences and Healthcare related reports, please click here
0 notes
health-views-updates · 2 months
Text
The Future of the 3D Ultrasound Market: Insights and Projections
Tumblr media
3D Ultrasound Market Outlook, Scope & Overview:
Industry reports indicate that the global 3D ultrasound market was estimated at USD 3.89 billion in 2023 and is poised to reach USD 6.59 billion by 2031, expanding at a compound annual growth rate (CAGR) of approximately 6.8% over the forecast period 2024-2031.
Technological Advancements to Drive Growth of Global 3D Ultrasound Market
The adoption of advanced 3D ultrasound technologies will continue to influence global market revenues. Healthcare providers are increasingly utilizing 3D ultrasound imaging to enhance diagnostic accuracy, improve patient outcomes, and provide better visualization of internal body structures.
As a product segment, portable 3D ultrasound devices currently hold a significant share of the global 3D ultrasound market. This segment is anticipated to grow at a year-over-year rate of 6.8% in 2024 over 2023 and reach USD 6.59 billion in revenues by 2031. The increasing demand for point-of-care diagnostics and the growing prevalence of chronic diseases are expected to drive market growth.
Get a Free Sample Report: https://www.snsinsider.com/sample-request/3099
3D Ultrasound Solutions – Market Dynamics
Drivers:
3D ultrasound solutions are witnessing significant growth in the global market due to their ability to provide detailed imaging, real-time visualization, and non-invasive diagnostics. The advancements in ultrasound technology, such as enhanced image quality and the integration of AI for automated image analysis, are key factors driving the adoption of 3D ultrasound systems worldwide. Additionally, the growing demand for prenatal imaging, cardiology, and oncology applications is further propelling market growth.
Restraints:
Despite the growth potential, challenges such as the high cost of advanced 3D ultrasound systems, the need for skilled operators, and limited accessibility in low-resource settings are hindering the widespread adoption of 3D ultrasound solutions. Moreover, concerns regarding the potential risks associated with prolonged ultrasound exposure and regulatory compliance requirements pose additional challenges to market expansion.
3D Ultrasound Solutions – Market Outlook
The proven benefits of 3D ultrasound solutions in enhancing diagnostic precision, improving patient care, and reducing the need for invasive procedures have contributed to the market's growth. 3D ultrasound systems are expected to witness increased adoption across major healthcare markets, including North America, Europe, and Asia Pacific, driven by technological advancements and the growing focus on personalized medicine.
Global 3D Ultrasound Market
The rise in demand for 3D ultrasound solutions in developed and emerging markets is expected to drive market growth over the forecast period. North America currently holds a significant market share in the global 3D ultrasound market, with the US being a key contributor to market revenues. Europe and Asia Pacific regions are also experiencing rapid adoption of 3D ultrasound solutions, supported by increasing healthcare investments and advancements in medical imaging technologies.
Key Players in the 3D Ultrasound Market
Leading companies in the 3D ultrasound market include GE Healthcare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems Corporation. These companies are at the forefront of developing and commercializing advanced 3D ultrasound systems for various healthcare applications, including obstetrics, cardiology, and oncology.
In conclusion, the global 3D ultrasound market is poised for substantial growth over the forecast period, driven by technological advancements, increasing healthcare demands, and the expanding adoption of advanced imaging solutions across diverse medical specialties.
Other Trending Reports
Dermal Fillers Industry Growth
Healthcare Data Storage Industry Growth
Neurorehabilitation Industry Growth
Healthcare Workforce Management Systems Industry Growth
0 notes
Text
The global demand for Brain Health Devices was valued at USD 11254.20 million in 2023 and is expected to reach USD 16724.81 million in 2032, growing at a CAGR of 4.50% between 2024 and 2032.The brain health devices market is witnessing significant growth, driven by increasing awareness of neurological disorders, advancements in technology, and a growing aging population. These devices, designed to monitor, diagnose, and treat brain-related conditions, are becoming indispensable tools in both clinical and home settings. This article explores the key drivers, trends, and future prospects of the brain health devices market.
Browse the full report at https://www.credenceresearch.com/report/brain-health-devices-market
Market Drivers
1. Rising Prevalence of Neurological Disorders: The global incidence of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, and epilepsy is on the rise. According to the World Health Organization (WHO), neurological disorders are a major cause of disability and death worldwide. This has created a pressing need for effective diagnostic and therapeutic solutions, fueling the demand for brain health devices.
2. Technological Advancements: Innovations in technology have led to the development of more sophisticated and accurate brain health devices. For instance, advancements in neuroimaging techniques, such as functional MRI (fMRI) and positron emission tomography (PET), have revolutionized the way neurological conditions are diagnosed and monitored. Additionally, the integration of artificial intelligence (AI) and machine learning (ML) in these devices has enhanced their predictive capabilities, enabling early diagnosis and personalized treatment plans.
3. Aging Population: The global population is aging, with a significant increase in the number of individuals over the age of 60. This demographic is more susceptible to neurological disorders, driving the demand for brain health devices. According to the United Nations, the number of people aged 60 and above is expected to double by 2050, highlighting the growing market potential.
4. Increased Awareness and Government Initiatives: Public awareness about brain health and neurological conditions has improved significantly, partly due to various government initiatives and campaigns. Programs aimed at educating the public and healthcare professionals about early detection and management of neurological disorders have played a crucial role in market growth. Additionally, favorable government policies and funding for research and development in the field of neuroscience have further propelled the market.
Market Segmentation
1. By Product Type: - Neurostimulation Devices: These include deep brain stimulators, spinal cord stimulators, and vagus nerve stimulators, which are used to treat conditions like Parkinson’s disease and epilepsy. - Neurodiagnostic Devices: This category encompasses electroencephalography (EEG) devices, magnetoencephalography (MEG) devices, and near-infrared spectroscopy (NIRS) devices, used for diagnosing and monitoring neurological disorders. - Neurorehabilitation Devices: These devices, such as brain-computer interfaces (BCIs) and robotic systems, are designed to aid in the rehabilitation of patients with neurological impairments.
2. By End-User: - Hospitals and Clinics: These facilities are the primary users of brain health devices, given their capability to provide comprehensive diagnostic and therapeutic services. - Home Care Settings: With the advent of portable and user-friendly devices, there is a growing trend towards home-based monitoring and treatment of neurological conditions. - Research and Academic Institutes**: These institutions utilize brain health devices for conducting research and developing new treatment methodologies.
Regional Insights
The brain health devices market is geographically segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
- North America: This region dominates the market due to advanced healthcare infrastructure, high healthcare expenditure, and significant investments in R&D. The presence of major market players and favorable reimbursement policies also contribute to market growth. - Europe: Europe holds a significant share of the market, driven by increasing prevalence of neurological disorders and robust healthcare systems. - Asia-Pacific: This region is expected to witness the fastest growth, attributed to rising awareness, improving healthcare infrastructure, and increasing healthcare expenditure in countries like China and India.
Future Prospects
The future of the brain health devices market looks promising, with continuous advancements in technology and growing investment in neurological research. Personalized medicine, driven by AI and big data analytics, is expected to revolutionize the field, offering tailored treatment plans for individuals based on their genetic and environmental profiles. Additionally, the integration of brain health devices with wearable technology and mobile health applications is likely to enhance patient engagement and adherence to treatment protocols.
Key Players
BrainScope Company, Inc.
Bio-Signal Group Corp.
Cadwell Industries, Inc.
Advanced Brain Monitoring, Inc.
Compumedics Ltd.
Elekta
DePuy Synthes
Electrical Geodesics, Inc.
Medtronic
GE Healthcare
MEG International Services Ltd.
Natus Medical, Inc.
Neurowave Systems Inc.
Nihon Kohden Corporation
Philips Healthcare
Segmentation
By Neurostimulation Devicess
Deep Brain Stimulation (DBS) Devices
Transcranial Magnetic Stimulation (TMS) Devices
Vagus Nerve Stimulation (VNS) Devices
By Neuroimaging Devices
MRI Scanners
CT Scanners
PET and SPECT Scanners
By Neurosurgical Devices
Neurosurgical Navigation Systems
Neuroendoscopes
Cerebrospinal Fluid (CSF) Shunts
By Brain Monitoring Devices
EEG Monitors
Cerebral Oximeters
Intracranial Pressure Monitors
By Neurocognitive Assessment Devices
Neuropsychological Test Batteries
Virtual Reality Platforms
Brain-Computer Interface Systems
By Region
North America
US
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
Browse the full report at https://www.credenceresearch.com/report/brain-health-devices-market
About Us:
Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.
Contact:
Credence Research
Please contact us at +91 6232 49 3207
Website: www.credenceresearch.com
0 notes
industryupdates101 · 6 months
Text
0 notes
lovelypol · 6 months
Text
0 notes
clearmusictheorist · 11 months
Text
0 notes
healthtechpulse · 2 months
Link
0 notes
ramkumarss · 1 year
Text
Neurorehabilitation Market size was valued at USD 1.26 billion in 2022 and is poised to grow at a significant CAGR of 12.4% from 2023 to 2029. Neurorehabilitation is the medical procedure that aims to recover the nervous system injury that results in the functional nervous system from the non-functional nervous system and improve the well-being of an individual. Neurorehabilitation devices are used in Parkinson's disease, cerebral palsy, multiple sclerosis, stroke recovery, and brain injury among others. The neurorehabilitation procedure allows for the reduction of deficits and impairments, thereby enhancing the patient's quality of life. Neurorehabilitation devices include invasive stimulators, non-invasive stimulators, neurorobotics, and brain-computer interfaces. Global market exhibiting lucrative growth owing to increase in the prevalence of neurovascular diseases. Request Sample : https://www.precisionbusinessinsights.com/request-sample/?product_id=19295
0 notes